Michael Sinden
Chief Brand Officer (CBO) at @ionopticks.bsky.social
LC-MS. Chromatography. Tech. Brand. Design.
@micromics.bsky.social
Enhancing LC-MS Workflows for Unparalleled Sensitivity and Throughput in Proteomics.
@msacl-org.bsky.social
Mass Spectrometry & Advances in the Clinical Lab. A non-profit committed to supporting the translation of pre-clinical research to clinical patient care. msacl.org
@thetiredscientist.bsky.social
don’t tell me you aren’t ✉️ you can also dm me your fav sci memes to post here
@patiskowronek.bsky.social
Proteomics Researcher @MannLab - Max Planck Institute | PhD Biochemistry | Mass Spectrometry Expert | Bioinformatics | Aiming to Democratize Life Science with GenAI
@mbp-rnc.bsky.social
Enabling Researchers to Focus on Breakthroughs. Specializing in grant writing to support researchers to secure funding and drafting articles to communicate their work. Expertise: chemical R&D, lab automation, scientific writing. (https://www.mbp-rnc.com/)
@hecklab.bsky.social
Professor in Biomolecular Mass Spectrometry and Proteomics, Utrecht University, the Netherlands
@denvms.bsky.social
The Dutch Society for Mass Spectrometry (NVMS) aims to connect scientists from various fields of mass spectrometry and foster interactions among members from academia and industry, bridging the gap between young and experienced mass spectrometrists.
@ardalansaki.bsky.social
Pharmaceutical /Organic Chemistry / Drug Discovery /Peptide-based synthesis /CADD/AlphaFold / Bioinformatic Google Scholar: https://scholar.google.com/citations?hl=en&user=kx4ua4MAAAAJ&view_op=list ORCID ID: https://orcid.org/0009-0004-2961-2649
@immatthewp.bsky.social
Empowering Researchers to Focus on Breakthroughs. Specializing in grant writing support to help researchers secure funding and draft articles. Expertise in chemical R&D, lab automation, impactful scientific communication. (https://www.mbp-rnc.com/)
@biognosys.bsky.social
Transforming life sciences with cutting-edge #proteomics technology and solutions
@rossolllab.bsky.social
Translational Neuroproteomics Lab | Understanding mechanisms of protein (dis)aggregation in neurodegenerative diseases | Views = own
@amberkhamilton.bsky.social
Post-Doc CHOP: mass spectrometry, immunotherapy, epigenetics, pediatric cancer and advocacy | UPenn GCB & Arcadia
@nanopots.bsky.social
Scientist @Genentech love all small and automated devices, mass spectrometry, protein-protein interactions, cell-cell interactions, and how to make peptides/proteins flying into vacuum; View are my own
@chrisdwhelan.bsky.social
Director of Neuroscience Data Science at J&J. Interested in population proteomics, genetics, neuroscience & biomarker development. 🇮🇪🧠🧬
@keribackus.bsky.social
Associate Professor at UCLA, all things chemical biology, chemoproteomic-, covalent-, cysteine- and redox-related
@rah37ds.bsky.social
Large-scale Proteomics (clincial & single-cell), mass spectrometry, biostatistics, machine learning, multi-omics.
@seebj.bsky.social
Proteomics Core Facility at Friedrich-Miescher Institute (FMI) Basel, @fmiscience.bsky.social. #massspectrometry, #proteomics, #chemistry, #bioinformatics
@ozglyco.bsky.social
The Australian Glycoscience Society | http://ozglyco.org
@altmetric.com
We measure the attention that research outputs receive from policy documents, mainstream news outlets, social media and online reference managers. Come for the attention to research. Stay for the memes.
@joelooucla.bsky.social
UCLA Department of Chemistry and Biochemistry. Better living through mass spectrometry.
@jeremylshane.bsky.social
Working to end chronic disease with Life for Health. Writings at https://hardproblems.substack.com. Formerly Webmd/Medscape, 2U, HealthCentral, Exelon
@noeinan.bsky.social
🏳️⚧️♿️🏳️🌈🏳️🌈🇺🇦🏳️🌈🏳️🌈♿️🏳️⚧️ Making wire sculptures of birds + other crafts he/they
@cinderbio.bsky.social
Extreme enzymes for #proteomics and specialty applications. One-step/5-minute digests w/ orthogonal coverage to trypsin; Bias for #membraneproteins. Link to Journal of Proteomics paper (https://c-bio.link/JPBJrW) Berkeley, CA CinderBio.com
@softwareiq.io
A modern research platform purposefully built for the software industry. Now available in public preview, sign-up today! softwareiq.io
@mattbritz.bsky.social
Formerly CEO of AffyImmune, CAR-T for solid tumors. Currently looking for what’s next.